Qube Research & Technologies (QRT)
KDNY

Qube Research & Technologies (QRT)’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,598
Closed -$220K – 3201
2022
Q2 		$220K Buy
+12,598
New +$198K ﹤0.01% 1696

Other funds holding KDNY

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s KDNY Position: Q3 2022 in Review

Qube Research & Technologies (QRT) sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2022, closing a stake of 12,598 shares — an estimated $220K sold.

Qube Research & Technologies (QRT) first reported a position in KDNY in Q2 2022 and held it in 1 quarter. The position peaked at $220K in Q2 2022. 151 funds tracked by Wall St. Rank hold KDNY as of Q3 2022.

  • Qube Research & Technologies (QRT) reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 12,598 Chinook Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $220K.
  • Qube Research & Technologies (QRT) first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Chinook Therapeutics, Inc. Common Stock position peaked at $220K in Q2 2022.
  • 151 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2022, filed 14 Nov 2022.